Cargando…
A new method for the high-precision assessment of tumor changes in response to treatment
MOTIVATION: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both development and also in response to treatment. The large variations observed in control group, tumors can obscure detection of si...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061877/ https://www.ncbi.nlm.nih.gov/pubmed/29547950 http://dx.doi.org/10.1093/bioinformatics/bty115 |
_version_ | 1783342307328655360 |
---|---|
author | Tar, P D Thacker, N A Babur, M Watson, Y Cheung, S Little, R A Gieling, R G Williams, K J O’Connor, J P B |
author_facet | Tar, P D Thacker, N A Babur, M Watson, Y Cheung, S Little, R A Gieling, R G Williams, K J O’Connor, J P B |
author_sort | Tar, P D |
collection | PubMed |
description | MOTIVATION: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both development and also in response to treatment. The large variations observed in control group, tumors can obscure detection of significant therapeutic effects due to the ambiguity in attributing causes of change. This can hinder development of effective therapies due to limitations in experimental design rather than due to therapeutic failure. An improved method to model biological variation and heterogeneity in imaging signals is described. Specifically, linear Poisson modeling (LPM) evaluates changes in apparent diffusion co-efficient between baseline and 72 h after radiotherapy, in two xenograft models of colorectal cancer. The statistical significance of measured changes is compared to those attainable using a conventional t-test analysis on basic apparent diffusion co-efficient distribution parameters. RESULTS: When LPMs were applied to treated tumors, the LPMs detected highly significant changes. The analyses were significant for all tumors, equating to a gain in power of 4-fold (i.e. equivalent to having a sample size 16 times larger), compared with the conventional approach. In contrast, highly significant changes are only detected at a cohort level using t-tests, restricting their potential use within personalized medicine and increasing the number of animals required during testing. Furthermore, LPM enabled the relative volumes of responding and non-responding tissue to be estimated for each xenograft model. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers, raising confidence in LPM data at clinically relevant sample sizes. AVAILABILITY AND IMPLEMENTATION: TINA Vision open source software is available from www.tina-vision.net. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. |
format | Online Article Text |
id | pubmed-6061877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60618772018-08-07 A new method for the high-precision assessment of tumor changes in response to treatment Tar, P D Thacker, N A Babur, M Watson, Y Cheung, S Little, R A Gieling, R G Williams, K J O’Connor, J P B Bioinformatics Original Papers MOTIVATION: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both development and also in response to treatment. The large variations observed in control group, tumors can obscure detection of significant therapeutic effects due to the ambiguity in attributing causes of change. This can hinder development of effective therapies due to limitations in experimental design rather than due to therapeutic failure. An improved method to model biological variation and heterogeneity in imaging signals is described. Specifically, linear Poisson modeling (LPM) evaluates changes in apparent diffusion co-efficient between baseline and 72 h after radiotherapy, in two xenograft models of colorectal cancer. The statistical significance of measured changes is compared to those attainable using a conventional t-test analysis on basic apparent diffusion co-efficient distribution parameters. RESULTS: When LPMs were applied to treated tumors, the LPMs detected highly significant changes. The analyses were significant for all tumors, equating to a gain in power of 4-fold (i.e. equivalent to having a sample size 16 times larger), compared with the conventional approach. In contrast, highly significant changes are only detected at a cohort level using t-tests, restricting their potential use within personalized medicine and increasing the number of animals required during testing. Furthermore, LPM enabled the relative volumes of responding and non-responding tissue to be estimated for each xenograft model. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers, raising confidence in LPM data at clinically relevant sample sizes. AVAILABILITY AND IMPLEMENTATION: TINA Vision open source software is available from www.tina-vision.net. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2018-08-01 2018-03-14 /pmc/articles/PMC6061877/ /pubmed/29547950 http://dx.doi.org/10.1093/bioinformatics/bty115 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Papers Tar, P D Thacker, N A Babur, M Watson, Y Cheung, S Little, R A Gieling, R G Williams, K J O’Connor, J P B A new method for the high-precision assessment of tumor changes in response to treatment |
title | A new method for the high-precision assessment of tumor changes in response to treatment |
title_full | A new method for the high-precision assessment of tumor changes in response to treatment |
title_fullStr | A new method for the high-precision assessment of tumor changes in response to treatment |
title_full_unstemmed | A new method for the high-precision assessment of tumor changes in response to treatment |
title_short | A new method for the high-precision assessment of tumor changes in response to treatment |
title_sort | new method for the high-precision assessment of tumor changes in response to treatment |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061877/ https://www.ncbi.nlm.nih.gov/pubmed/29547950 http://dx.doi.org/10.1093/bioinformatics/bty115 |
work_keys_str_mv | AT tarpd anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT thackerna anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT baburm anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT watsony anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT cheungs anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT littlera anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT gielingrg anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT williamskj anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT oconnorjpb anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT tarpd newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT thackerna newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT baburm newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT watsony newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT cheungs newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT littlera newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT gielingrg newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT williamskj newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment AT oconnorjpb newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment |